Related Experiment Videos
Prion-like characteristics of the bacterial protein Microcin E492
Mohammad Shahnawaz1, Kyung-Won Park1, Abhisek Mukherjee1
1Mitchell Center for Alzheimer's disease and related Brain Disorders, Department of Neurology, University of Texas Houston Medical School, Houston, Texas, USA.
Abstract:
Microcin E492 (Mcc) is a pore-forming bacteriotoxin. Mcc activity is inhibited at the stationary phase by formation of amyloid-like aggregates in the culture. Here we report that, in a similar manner as prions, Mcc naturally exists as two conformers: a β-sheet-rich, protease-resistant, aggregated, inactive form (Mccia), and a soluble, protease-sensitive, active form (Mcca). The exogenous addition of culture medium containing Mccia or purified in vitro-generated Mccia into the culture induces the rapid and efficient conversion of Mcca into Mccia, which is maintained indefinitely after passaging, changing the bacterial phenotype. Mccia prion-like activity is conformation-dependent and could be reduced by immunodepleting Mccia. Interestingly, an internal region of Mcc shares sequence similarity with the central domain of the prion protein, which is key to the formation of mammalian prions. A synthetic peptide spanning this sequence forms amyloid-like fibrils in vitro and is capable of inducing the conversion of Mcca into Mccia in vivo, suggesting that this region corresponds to the prion domain of Mcc. Our findings suggest that Mcc is the first prokaryotic protein with prion properties which harnesses prion-like transmission to regulate protein function, suggesting that propagation of biological information using a prion-based conformational switch is an evolutionary conserved mechanism.
Insights
Microcin E492 (Mcc) exhibits prion-like behavior, switching between active and inactive aggregated forms. This conformational change, driven by a prion-like domain, regulates bacterial function and is conserved across evolution.
Area of Science:
- Microbiology
- Biochemistry
- Structural Biology
Background:
- Microcin E492 (Mcc) is a pore-forming bacteriotoxin.
- Mcc activity is regulated by aggregation into amyloid-like structures during the stationary phase.
Purpose of the Study:
- To investigate the prion-like properties of Microcin E492.
- To identify the mechanism of Mcc conformational switching and its functional implications.
Main Methods:
- Conformational analysis of Mcc in active (Mcc a) and inactive (Mcc ia) states.
- In vitro and in vivo conversion assays using purified Mcc ia and synthetic peptides.
- Immunodepletion studies to assess the role of Mcc ia.
Main Results:
- Mcc exists in two stable conformers: soluble active (Mcc a) and aggregated inactive (Mcc ia).
- Exogenous Mcc ia induces rapid and stable conversion of Mcc a to Mcc ia, altering bacterial phenotype.
- A Mcc internal region shares sequence similarity with mammalian prion protein's central domain, acting as a prion domain.
Conclusions:
- Mcc is the first prokaryotic protein demonstrating prion properties.
- Mcc harnesses prion-like transmission to regulate protein function.
- Prion-based conformational switching is an evolutionarily conserved mechanism for biological information propagation.